Verified peer comparison
Rubico vs Tvardi Therapeutics Financial Comparison
Direct answer
Rubico and Tvardi Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Rubico email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Rubico Revenue
- 23,523,000 USD
- Tvardi Therapeutics Revenue
- 0 USD
- Rubico Operating income
- 12,400,000 USD
- Tvardi Therapeutics Operating income
- -26,748,000 USD